Antxon Apiñaniz
Vitoria-Gasteiz, Alava, Spain
NCT Number: NCT06820775
Diabetes represents a substantial burden on health care systems. People with prediabetes IGT (impaired glucose tolerance) or IFG (impaired fasting glucose) are at high risk of developing diabetes, and up to 50% progress to diabetes within 5 years.
OBJECTIVE: To evaluate the effectiveness of a triple intervention (physical activity and ordered healthy diet) to improve glycosylated hemoglobin control in prediabetic patients.
MATERIAL AND METHODOLOGY: Randomized, open, controlled clinical trial with routine clinical practice (health advice for physical activity and healthy diet). Study population: obese or overweight patients of the OSI Araba aged 35-70 years who are in the contemplation stage.
Response assessment: Primary variable: glycosylated hemoglobin; Secondary variables: Body Mass Index (BMI) (kg/cm2); blood pressure (mm Hg); satisfaction questionnaire score; physical exercise index (IPAQ) (METs). Statistical analysis: The analysis of the main variable (change in HbA1c at 6 months between both groups) will be assessed by analysis of covariance, ANCOVA, adjusting for baseline HbA1c. Sample size: 41 patients per arm (+30% to cover losses to follow-up).
Trial opening soon.
Get Notified35 year–70 year
All sexes
Interventional
Not applicable
Vitoria-Gasteiz, Alava, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Prediabetics with glycosylated hemoglobin (HbA1c) 5.7-6.4 (24, 38) and signing informed consent.
-
Exclusion criteria
Presence of physical or psychological illnesses that prevent physical activity; participation in another research project; pregnancy or breastfeeding; patients undergoing dietary or pharmacological treatment for weight loss; history of myocardial infarction or stroke; diabetic, taking drugs for diabetes mellitus and taking drugs such as Gliflozin for pathologies other than diabetes mellitus.
of physical or psychological illnesses that prevent physical activity; participation in another research project; pregnancy or breastfeeding; patients undergoing dietary or pharmacological treatment for weight loss; history of myocardial infarction or stroke; diabetic, taking drugs for diabetes mellitus and taking drugs such as Gliflozin for pathologies other than diabetes mellitus.
Intervention group: Health advice and triple intervention: 15 ml apple cider vinegar diluted in a glass of water before meals, order in the sequence of meals (sequence of food intake: first vegetables, second proteins, third fats and finally carbohydrates) and physical activity immediately after meals.
Description of all interventions:
Patients in both groups: all patients will receive health advice on sports practice from the WHO, Osakidetza and the Basque Government.
Time frame: At baseline, 3 and 6 months
Glycated hemoglobin (HbA1c)
Time frame: At baseline, 3 and 6 months
BMI (kg/cm2)
Time frame: At 6 months
Score in the satisfaction questionnaire
Time frame: At baseline, 3 and 6 months
Physical exercise index (IPAQ)
Time frame: At 3 and 6 months
Compliance with the triple dietary intervention
Time frame: At 3 and 6 months
Prcentage of patients who reach normoglycemia (HbA1c < 5.7).
Contact information is provided by the study sponsor or research team.
Bioaraba Health Research Institute
Network
EFFECTIVENESS OF A TRIPLE NUTRITIONAL INTERVENTION AND PHYSICAL ACTIVITY FOR GLYCOSYLATED HB CONTROL IN PREDIABETICS: CLINICAL TRIAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07388537
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT07313787
Diabetes, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT06645769
Diabetes, Diabetes Mellitus
View Trial DetailsNCT07723222
Apnea, Cardiovascular Autonomic Neuropathy (CAN)
View Trial Details